Gain Therapeutics's market cap is currently $62.07M. The company's EPS TTM is $-1.107; its P/E ratio is ―; Gain Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 55.18K	$ 140.11K	$ 164.99K	$ 28.88K	$ 41.30K
Gross Profit	$ -25.20K	$ 75.94K	$ -7.00M	$ -2.23M	$ 41.30K
Operating Income	$ -22.25M	$ -17.78M	$ -13.83M	$ -3.48M	$ -2.10M
EBITDA	$ -22.17M	$ -17.78M	$ -13.82M	$ -3.47M	$ -2.10M
Net Income	$ -22.27M	$ -17.59M	$ -13.89M	$ -3.58M	$ -2.19M
Balance Sheet
Cash & Short-Term Investments	$ 16.79M	$ 20.14M	$ 36.88M	$ 7.49M	$ 303.32K
Total Assets	$ 18.61M	$ 24.10M	$ 38.99M	$ 9.60M	$ 660.29K
Total Debt	$ 1.03M	$ 1.27M	$ 1.61M	$ 1.26M	$ 200.95K
Net Debt	$ -10.77M	$ -6.04M	$ -35.27M	$ -6.23M	$ -102.37K
Total Liabilities	$ 6.03M	$ 5.22M	$ 4.17M	$ 3.40M	$ 1.11M
Stockholders' Equity	$ 12.58M	$ 18.88M	$ 34.82M	$ 6.20M	$ -449.86K
Cash Flow
Free Cash Flow	$ -18.88M	$ -14.81M	$ -12.46M	$ -3.26M	$ -1.88M
Operating Cash Flow	$ -18.87M	$ -14.69M	$ -12.37M	$ -3.24M	$ -1.87M
Investing Cash Flow	$ 10.22M	$ -14.77M	$ -94.21K	$ -20.83K	$ -13.72K
Financing Cash Flow	$ 12.64M	$ -78.77K	$ 41.77M	$ 10.49M	$ 1.75M

Currency in USD

Gain Therapeutics Earnings and Revenue History

Income Statement >

Gain Therapeutics Debt to Assets

Balance Sheet >

Gain Therapeutics Cash Flow

Cash Flow >

Gain Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing